Published in J Lab Clin Med on April 01, 1995
Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis (2002) 1.47
Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A (1998) 1.24
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian J Med Res (2013) 0.79
Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy. PLoS One (2016) 0.77
Oxidized proportion of muscle coenzyme Q10 increases with age in healthy children. Pediatr Res (2015) 0.75
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet (1994) 3.72
Lower patients' cholesterol now. BMJ (1995) 3.23
Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet (1999) 2.63
A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther (1993) 1.45
Assessment of the state-of-the-art trueness and precision of serum total-calcium and glucose measurements in Finnish laboratories--the QSL-Finland study. Scand J Clin Lab Invest (1998) 1.38
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
Evidence of a state of increased insulin resistance in preeclampsia. Metabolism (1999) 1.31
Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol (1995) 1.13
A method for the quantitative determination of urinary estriol conjugates in human pregnancy. J Steroid Biochem (1972) 1.12
Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb (1994) 1.11
Relation of aortic stiffness to factors modifying the risk of atherosclerosis in healthy people. Arterioscler Thromb (1994) 1.11
Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol (1994) 1.11
Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest (1985) 1.10
Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults. J Intern Med (1997) 1.09
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone. Diabetologia (2003) 1.06
Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab (1996) 1.05
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther (2000) 1.03
The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am J Cardiol (1996) 1.02
Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample. Am J Cardiol (1993) 1.01
Intestinal metabolism of estrogens. J Clin Endocrinol Metab (1976) 1.01
Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet (1978) 1.01
Adenosylmethionine decarboxylase from various organisms: relation of the putrescine activation of the enzyme to the ability of the organism to synthesize spermine. Biochem Biophys Res Commun (1976) 0.98
Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene. Am J Hum Genet (1992) 0.97
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo. Clin Pharmacol Ther (2008) 0.96
Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J (1987) 0.95
Effect of age on amnesia and sedation induced by flunitrazepam during local anaesthesia for bronchoscopy. Br J Anaesth (1978) 0.94
Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate. Clin Pharmacol Ther (2001) 0.94
Putrescine-insensitive S-adenosyl-L-methionine decarboxylase from Tetrahymena pyriformis. Acta Chem Scand B (1975) 0.93
Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol (1989) 0.93
Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol (1990) 0.93
Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland. Am J Cardiol (1999) 0.92
Subannual models for catchment management: evaluating model performance on three European catchments. J Environ Monit (2009) 0.92
Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol (2012) 0.91
Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol. Atherosclerosis (1990) 0.91
Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension (1998) 0.90
Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol (1999) 0.90
Effect of ampicillin treatment on the urinary excretion of estriol conjugates in pregnancy. J Steroid Biochem (1973) 0.89
Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation. Climacteric (2007) 0.88
Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis (1999) 0.88
Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride. Clin Pharmacol Ther (2001) 0.87
Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res (1990) 0.87
Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol (2000) 0.87
Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. Am J Obstet Gynecol (1977) 0.87
Risk factors predicting chronic rejection of renal allografts. Transplantation (1994) 0.86
Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther (1995) 0.86
Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. J Lipid Res (1988) 0.85
Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus. Acta Anaesthesiol Scand (1988) 0.85
Midazolam as an induction agent in children: a pharmacokinetic and clinical study. Anesth Analg (1987) 0.84
Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr (2006) 0.84
Effects of antibiotics on oestrogen metabolism. Br Med J (1973) 0.84
High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab (1982) 0.84
XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis (1988) 0.84
Ubiquinone supplementation and exercise capacity in trained young and older men. Eur J Appl Physiol Occup Physiol (1995) 0.84
Current pharmacologic treatment of elevated serum cholesterol. Circulation (1987) 0.84
Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. Atherosclerosis (1982) 0.83
Ag system re-explored: studies with monoclonal anti-apolipoprotein B antibodies. Adv Exp Med Biol (1987) 0.83
Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein. Biochim Biophys Acta (1999) 0.83
Placental transfer and maternal midazolam kinetics. Clin Pharmacol Ther (1983) 0.82
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast. Clin Pharmacol Ther (2010) 0.82
Hypothyroidism following subacute thyroiditis. Acta Endocrinol (Copenh) (1982) 0.82
Midazolam versus atropine plus pethidine as premedication in children. Anaesthesia (1984) 0.82
Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia. J Intern Med (1991) 0.82
Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum. J Clin Endocrinol Metab (1974) 0.82
The usefulness of radioreceptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam. Int J Clin Pharmacol Ther Toxicol (1985) 0.82
Safety assessment of common foods enriched with natural nonesterified plant sterols. Eur J Clin Nutr (2008) 0.81
Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions. Studies with monoclonal antibodies. Arteriosclerosis (1984) 0.81
Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. J Clin Endocrinol Metab (2005) 0.81
Effect of ampicillin administration on the excretion of twelve oestrogens in pregnancy urine. Acta Endocrinol (Copenh) (1975) 0.81
Comparison of diazepam and flunitrazepam for sedation during local anaesthesia for bronchoscopy. Br J Anaesth (1978) 0.81
Recurrent jaundice in pregnancy. 3. Quantitative determination of urinary estriol conjugates, including studies in pruritus gravidarum. Am J Med (1973) 0.81
A monoclonal antibody (BIP 45) detects Ag(c,g) polymorphism of human apolipoprotein B. J Immunol Methods (1987) 0.81
Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors. Eur J Clin Pharmacol (1994) 0.81
Beneficial effects of a potassium- and magnesium-enriched salt alternative. Hypertension (1992) 0.81
Defects in hepatic uptake and transport and biliary excretion of estrogens. Some new concepts of liver metabolism. Med Chir Dig (1973) 0.81
Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism (1986) 0.81
Limited proteolysis selectively destroys epitopes on apolipoprotein B in low density lipoproteins. J Lipid Res (1983) 0.80
New data for AG haplotype frequencies in Caucasoid populations and selective neutrality of the AG polymorphism. Hum Biol (1994) 0.80
Changes in the urinary oestriol conjugate pattern in twin pregnancy. J Endocrinol (1972) 0.80
Dietary habits affect the susceptibility of low-density lipoprotein to oxidation. Eur J Clin Nutr (1999) 0.80
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial. J Intern Med (2009) 0.80
The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals. Nutr Metab Cardiovasc Dis (2011) 0.80
The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone. Eur J Clin Pharmacol (1999) 0.79
Rye bread intake improves oxidation resistance of LDL in healthy humans. Atherosclerosis (2012) 0.79
Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation (1993) 0.79
Low blood total cholesterol and mortality: causality, consequence and confounders. Am J Cardiol (1994) 0.79
Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Atherosclerosis (1990) 0.79
Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2. Atherosclerosis (1985) 0.79
Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy. Arch Neurol (1982) 0.79
Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen. Studies on the physiological role of hepatic endothelial lipase. FEBS Lett (1985) 0.79
Accumulation of high-density lipoprotein-derived estradiol-17beta fatty acid esters in low-density lipoprotein particles. J Clin Endocrinol Metab (2001) 0.79
Long-term tiapamil treatment of patients with angina pectoris. Clin Cardiol (1983) 0.79